1. Home
  2. OMER vs KODK Comparison

OMER vs KODK Comparison

Compare OMER & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$13.29

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

N/A

Current Price

$7.87

Market Cap

982.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
OMER
KODK
Founded
1994
1880
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
982.9M
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
OMER
KODK
Price
$13.29
$7.87
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $27.50
N/A
AVG Volume (30 Days)
★ 1.2M
825.5K
Earning Date
11-16-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 98.15
N/A
EPS
★ 0.13
0.11
Revenue
$29,868,000.00
★ $4,114,000,000.00
Revenue This Year
N/A
$10.63
Revenue Next Year
$66.13
$6.60
P/E Ratio
$107.77
★ $72.55
Revenue Growth
N/A
★ N/A
52 Week Low
$6.70
$6.54
52 Week High
$21.24
$14.87

Technical Indicators

Market Signals
Indicator
OMER
KODK
Relative Strength Index (RSI) 30.78 37.75
Support Level $9.45 $7.43
Resistance Level $19.68 $7.97
Average True Range (ATR) 0.92 0.42
MACD -0.45 -0.02
Stochastic Oscillator 8.90 27.85

Price Performance

Historical Comparison
OMER
KODK

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

Share on Social Networks: